Search

The broad market finally firmed up last week. After closing below their 50-day lines the previous Friday, the Dow, S&P 500 and Nasdaq all found support early last week, then rebounded strongly at the end of the week. However, while the market is firming, four of our holdings stumbled on earnings last week.

Stocks started off somewhat promisingly this week, with a huge plunge Monday morning followed by a massive reversal that afternoon. But stocks haven’t been able to build on that at all, with numerous intraday rally failures and with some indexes already probing lower lows, especially broader and growth-oriented indexes and funds.

The market’s snapback from its mid-December low has been solid—the S&P 500 being at new highs is never a bad thing, and by our measures, the market’s overall intermediate-term trend has turned back up.

It’s been a very impressive week for the market from a few angles. First, of course, was the snapback of the major indexes—the big-cap indexes, which never got taken apart, have recouped something like 80% of their pullbacks, and while the broader indexes haven’t bounced as much, (a) they did gain back more than half their declines, and (b) they actually perked above their 50-day lines earlier this week (the overall intermediate-term trend remains down, but bears watching).

MarketWatch again named Cabot China & Emerging Markets Report the top performing investment letter over the past 12 months, up a remarkable 61.45% vs. negative 2.63% for the dividend-reinvested Dow Jones Wilshire 5000.

It’s been another relatively quiet week for the major indexes, with most up in the 0.5% range, though the Nasdaq has outperformed, rising around 1.7% on the week as of this morning.

Things had been a bit too quiet in the market, and that usually results in some unexpected action, and we’re starting to see that now—many leading cyclical stocks and sectors have broken down, while yesterday, growth stocks (especially the winners from last year) ramped … basically, another big round of rotation. Today, though, we’re seeing the sellers hit everything, growth and cyclical alike.

It hasn’t been all bad over the past four or five weeks of course, but we did see an accumulation of yellow flags, including some big-volume selling, a thinning out of the advance, and the major indexes moving out of trend on the upside.

It’s been another good week for the major indexes—the big-cap S&P 500 and Nasdaq are again leading the way (up 2.5% to 3% coming into today), but even the broader indexes like small and mid-caps are up 1.5% or so.

It was a relatively quiet week looking at the major indexes, though yesterday (where there was a brief selling wave) and this morning (follow-on selling) has shaken things up a bit.

It’s been another tumultuous week in the market, though much of that occurred on Monday’s 12%-ish plunge in the major indexes.

As earnings season has picked up, we’ve been pleased to see mostly positive reactions across the market and individual stocks, including some potential fresh leaders.

The market has been extended and vulnerable to a sharp pullback for the past couple of weeks, and last night’s surprise attacks overseas provided a reason for the sellers to do some work—this morning, the major indexes and most stocks are taking a hit.

Whether it was a meltdown in Chinese stocks due to regulatory actions, fears of renewed virus restrictions (and mask mandates) or inflation jitters, the market is getting hit sharply today, and growth stocks are going along for the ride—as of 1 p.m. ET, the Dow is off 195 points, while the Nasdaq is down 291 points and growth-y indexes are down 3%-plus. We’re not going to draw a massive conclusion from one day of trading, especially as it comes on the heels of what was a darn good few days for growth stocks following last Monday’s shakeout. But it is a sign that the endless choppy phase might not be in the rearview mirror.

Donald Trump pulled the U.S. out of the Paris climate agreement, and that’s ostensibly bad news for Tesla. But will it actually impact TSLA stock?

Yesterday was another extremely volatile day in the stock market for options traders. Being patient is challenging for many traders, and especially options traders. We’re often looking for the next home run. However, in this environment, patience is key.

Once a high riser, the IHE biotech ETF has been stuck in the mud for two years. But that doesn’t mean you should tune out the biopharma industry as a whole.

Is your portfolio well-positioned to take advantage of the growing demand for building materials? If not, USG stock is a good place to start.

Tuesday’s better-than-expected GDP numbers should be a nice boost to growth stocks, even if it all but assures another interest rate hike later this month.

It’s been a solid week in the market, with the major indexes posting solid gains through Thursday. Interestingly, we came close to a legitimate blastoff signal yesterday (the Three Day Thrust), and if we see another 1% gain in the S&P 500 today, it would be a super bullish signal. That said, the market is indicated to open lower this morning, though the damage doesn’t seem too bad.